Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Seeing Machines Announces Groundbreaking Impairment Detection Capability 2025-09-09 20:00
Melitta Group becomes official coffee partner of Real Madrid 2025-09-09 10:15
$1M Forever: Halo's Enterprise Revolution Launches for Select Global Organisations 2025-09-09 00:42
Remplir™ Study Delivers Compelling 81% Success Rate 2025-09-08 17:32
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states 2025-08-27 20:00
China Accreditation Test for Translators and Interpreters Becomes the World's Largest Translation Test 2025-08-26 03:49
Heartbeats Launches Digital Wellness Platform Led by World-Renowned Heart Specialist Dr. Hosen Kiat 2025-08-22 13:22
FDA clearance of Salix® Coronary Plaque module 2025-08-21 19:43
Karpowership and Seatrium Launch LNGTS Americas and Sign LoI for Next-Gen Floating Power Projects 2025-08-14 18:36
Alpha Global partners with LIO to redefine Mental Health Care in Australia 2025-08-14 11:00
Australia's Prestigious Darwin Aboriginal Art Fair returns for its 19th Year, and you can access it online! 2025-08-08 08:35
X‑Design Tops Product Hunt with One-Click Lifestyle Product Photos 2025-08-08 03:01
Vmake AI Talking Video Editor: The All-in-One Solution for Talking Videos, Empowering Diverse Creators 2025-08-08 03:00
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market 2025-08-01 20:00
A novel oral treatment for Alzheimer's: Actinogen's pivotal trial currently recruiting participants in the US 2025-07-22 20:00
Co-PSMA trial: Recruitment successfully completed 2025-07-17 21:01
Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial 2025-07-09 20:00
Mindsprint enhances ProcureSPRINT™ with Agentic AI to unlock up to 15% in procurement cost efficiencies 2025-07-09 14:37
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 2025-07-03 07:09
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer's disease trial and interim analysis timeline 2025-06-30 20:30